Mylan N.V., makers of the anti-allergic reaction EpiPen, announced programs Thursday to lower the device's cost after U.S. senators expressed outrage at the price increase.
The single-use auto-injection pens, used as dispensers of the medicine epinephrine in emergencies resulting from food allergies, were created by Merck Group in the 1970s, and were acquired by Mylan in 2007. A price increase, from $57 per pen in 2007 to about $500 per pen today, drew the anger, earlier this week, of four U.S. senators who asked Mylan for an explanation.
EpiPen maker offers patients $300 savings cards
A federal appeals court late Friday blocked the ability of doctors to prescribe the abortion pill...
A Pennsylvania court on Monday said that the state’s constitution guarantees a right to abortion while...
A former senior adviser at the National Institute of Allergy and Infectious Diseases is facing charges...
When Bug got home from school one winter afternoon in late 2024, his mother was on...
